Recasens M, Guiramand J, Nourigat A, Sassetti I, Devilliers G
Centre CNRS-INSERM de Pharmacologie-Endocrinologie, Rue de la Cardonille, 34094 Montpellier Cedex, France.
Neurochem Int. 1988;13(4):463-7. doi: 10.1016/0197-0186(88)90075-7.
Inositol phosphate synthesis elicited by excitatory amino acids was measured in rat forebrain synaptoneurosomes in presence of Li(+). Quisqualate (QA) was the most potent excitatory amino acid inducing inositol phosphate formation. This QA action was not blocked by any of the usual antagonists [glutamate-amino-methyl-sulphonate (GAMS); glutamate-diethyl-ester (GDEE); ?-d-glutamyl-glycine (?-DGG)] known to inhibit the QA-induced depolarization. The same was found for the most potent and selective QA antagonist reported so far [6-nitro-7-cyanoquinoxaline-2,3-dion (FG 9065)]. In addition, dl-?-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) a potent depolarizing agonist at the quisqualate receptor subtype was about 300 times less potent than quisqualate in increasing inositol phosphate accumulation. Our results provide the first pharmacological evidence indicating that a new quisqualate receptor subtype, tentatively termed sAA(2) is responsible for inositol phosphate formation.
在存在锂离子的情况下,在大鼠前脑突触神经小体中测量了由兴奋性氨基酸引发的肌醇磷酸合成。quisqualate(QA)是诱导肌醇磷酸形成的最有效的兴奋性氨基酸。这种QA作用不会被任何已知可抑制QA诱导的去极化的常见拮抗剂[谷氨酸-氨基甲基磺酸盐(GAMS);谷氨酸二乙酯(GDEE);γ-d-谷氨酰甘氨酸(γ-DGG)]所阻断。对于迄今为止报道的最有效和选择性的QA拮抗剂[6-硝基-7-氰基喹喔啉-2,3-二酮(FG 9065)]也是如此。此外,dl-γ-氨基-3-羟基-5-甲基-4-异恶唑丙酸(AMPA),一种在quisqualate受体亚型上的强效去极化激动剂,在增加肌醇磷酸积累方面的效力比quisqualate低约300倍。我们的结果提供了首个药理学证据,表明一种新的quisqualate受体亚型,暂称为sAA(2),负责肌醇磷酸的形成。